🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

3 recruiting trials

for Platelet Transfusion Refractoriness

Study of CM313(SC) Injection in Subjects With Platelet Transfusion Refractoriness NCT06792019Phase 1, Phase 21 site📍 Tianjin Keymed Biosciences Co.Ltd · Tests: CM313(SC) injection-low dose, CM313(SC) injection-high dose Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness NCT06254560Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Rituximab RN1201 Injection in the Treatment of Antibody-Mediated Diseases NCT07072247Phase 11 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: CD19 and BCMA-targeted allogeneic CAR-T cells
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy